Google says it has added some pharmaceutical-related products, including prescription drugs, to the ads being tested in AI Mode and AI Overviews. The test began this month and is limited to the United States, with standard text ads and Shopping ads appearing under a “Sponsored” label. The news was reported by an international search industry publication on October 13, 2026.
Drug ads appear on AI answer screens
The shift in search over the past few years can be summed up this way: from screens lined with blue links to screens where AI gathers information into an answer. Experiments to place ads on these new screens are steadily advancing. This latest news is about the test expanding to include pharmaceuticals.
A Google spokesperson said the company is testing standard text ads and Shopping ads in AI Mode and AI Overviews, and recently expanded the test to include some pharmaceutical-related products. These include prescription drugs, and the test is limited to the U.S. and began this month. At this point, there is no indication that readers in Japan will see these ads anytime soon.
AI Mode lets users carry out research conversationally within Google Search, while AI Overviews displays an AI-generated summary at the top of search results. Both are designed to make it easy to research a topic and read an answer on one screen, and ads will be placed within that experience.
The significance of pharmaceuticals
Ads for shoes or appliances appearing next to AI answers feel very different from ads for medicines. People searching because they are worried about their health are often looking for answers quickly.
AI summaries bring together multiple sources in a single passage. When an ad appears nearby, how well can users distinguish the two? That is a question of screen design, separate from the mere presence of advertising. In areas like medicine, which are closely tied to purchasing and health decisions, that design is likely to draw more attention than usual.
The announcement confirms only that the test has begun and outlines its scope. Its actual effects and safety implications remain to be seen. Here, we’ll distinguish the facts from what remains uncertain and take a closer look at how the screen may change.
The role of the “Sponsored” label
In this test, ads are said to appear in a section labeled “Sponsored.” Advertisers can use standard text ads and Shopping ads; the format has not been described as one in which ads are blended into the AI answers themselves.
That said, information currently available does not show where on the screen the label will appear or how prominent it will be. Even with the same wording, the layout can make a big difference in how easy ads are to distinguish. As the service expands, the details of its display specifications are likely to have an increasing impact on the user experience.
The expansion of ad placements also serves as a way to generate revenue and keep AI search free. If more users are satisfied with summaries and stop clicking through to links, ad placements will shift toward AI screens, too. Seen in that light, this move may be one part of a broader upheaval in search advertising, not just a development affecting pharmaceuticals.
Expansion without a policy change
What’s notable is that Google’s pharmaceutical advertising policies have not recently changed. The outlet that reported the news says Google told it there had been no recent policy changes. Updates to rules for drug-related ads were noted in October 2025 and March 2026, including changes in some countries and regions, but they do not appear to be directly connected to this test.
In other words, the ad rules have not changed; rather, types of ads that were already eligible have expanded into the new placements of AI Mode and AI Overviews. If we view this as existing systems gradually moving into new screens, similar expansions across other industries are quite possible in the future.
What is known so far—and what remains unconfirmed
The article’s author also says they searched AI Mode and AI Overviews for pharmaceutical ads but could not find any. The test is limited to a subset of users, so it appears that few people have seen the ads so far.
The number of ads to be shown, the criteria for eligible products and advertisers, the details of ad review, and their exact placement on screen have not been disclosed. The key fact to keep in mind is that this remains a trial in the United States, not a permanent launch.
As search becomes a place for AI-generated answers, what will ads look like beside them? This experiment in an area as close to everyday life as medicine may offer one clue.
Comments